Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AbbVie Submits IMBRUVICA® (ibrutinib) Phase III Combination Data to U.S. FDA
AbbVie Submits IMBRUVICA® (ibrutinib) Phase III Combination Data to U.S. FDA
AbbVie Submits IMBRUVICA® (ibrutinib) Phase III Combination Data to U.S. FDA
Submitted by
admin
on November 13, 2015 - 10:59am
Source:
Yahoo
News Tags:
AbbVie
Imbruvica
bendamustine
rituximab
chronic lymphocytic leukemia
FDA
Headline:
AbbVie Submits IMBRUVICA® (ibrutinib) Phase III Combination Data to U.S. FDA
Do Not Allow Advertisers to Use My Personal information
